Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/20197
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Colebatch, Andrew J | - |
dc.contributor.author | Dobrovic, Alexander | - |
dc.contributor.author | Cooper, Wendy A | - |
dc.date | 2019-01-29 | - |
dc.date.accessioned | 2019-02-04T23:34:05Z | - |
dc.date.available | 2019-02-04T23:34:05Z | - |
dc.date.issued | 2019-04 | - |
dc.identifier.citation | Journal of clinical pathology 2019; 72(4): 281-284 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/20197 | - |
dc.description.abstract | In this review, we summarise the function and structure of telomerase reverse transcriptase (TERT) in humans, including its regulation. The dysregulation of telomerase through TERT promoter mutations across a range of cancers is discussed. The molecular mechanism activated by TERT promoter mutations is outlined. Finally, the timing of TERT promoter mutations during carcinogenesis is reviewed in the context of their potential utility as clinical biomarkers of malignant transformation. | - |
dc.language.iso | eng | - |
dc.subject | cancer | - |
dc.subject | cancer genetics | - |
dc.subject | cancer research | - |
dc.title | TERT gene: its function and dysregulation in cancer. | - |
dc.type | Journal Article | - |
dc.identifier.journaltitle | Journal of clinical pathology | - |
dc.identifier.affiliation | Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia | - |
dc.identifier.affiliation | Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia | en |
dc.identifier.affiliation | Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia | en |
dc.identifier.affiliation | School of Cancer Medicine and Molecular Cancer Prevention Program, La Trobe University, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia | en |
dc.identifier.affiliation | Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia | en |
dc.identifier.affiliation | Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia | en |
dc.identifier.affiliation | School of Medicine, Western Sydney University, Sydney, New South Wales, Australia | en |
dc.identifier.doi | 10.1136/jclinpath-2018-205653 | - |
dc.identifier.orcid | 0000-0001-5418-4229 | - |
dc.identifier.orcid | 0000-0003-3414-112X | - |
dc.identifier.pubmedid | 30696697 | - |
dc.type.austin | Journal Article | - |
local.name.researcher | Dobrovic, Alexander | |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
crisitem.author.dept | Surgery (University of Melbourne) | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.